Co-Authors
This is a "connection" page, showing publications co-authored by Barry Jacobson and Ian Sanne.
Connection Strength
0,481
-
Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study). BMJ Med. 2023; 2(1):e000302.
Score: 0,220
-
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024 Feb 27; 42(6):1195-1199.
Score: 0,058
-
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022 06; 19(6):e1004024.
Score: 0,052
-
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
Score: 0,051
-
Allergic reactions to the Ad26.COV2.S vaccine in South Africa. J Allergy Clin Immunol Glob. 2022 Feb; 1(1):2-8.
Score: 0,050
-
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study. N Engl J Med. 2021 08 05; 385(6):570-571.
Score: 0,049